WSGR logoWSGR logo
WSGR logo
  • Experience
  • People
  • Insights
  • About Us
  • Careers

  • Practice Areas
  • Industries

  • Corporate
  • Intellectual Property
  • Litigation
  • Patents and Innovations
  • Regulatory
  • Technology Transactions

  • Capital Markets
  • Corporate Governance
  • Corporate Life Sciences
  • Derivatives
  • Emerging Companies and Venture Capital
  • Employee Benefits and Compensation
  • Energy and Climate Solutions
  • Executive Advisory Program
  • Finance and Structured Finance
  • Fund Formation
  • Greater China
  • Mergers & Acquisitions
  • Private Equity
  • Public Company Representation
  • Real Estate
  • Restructuring
  • Shareholder Engagement and Activism
  • Tax
  • U.S. Expansion
  • Wealthtech

  • Special Purpose Acquisition Companies (SPACs)

  • Environmental, Social, and Governance

  • AI and Data Center Infrastructure
  • Energy Regulation and Competition
  • Project Development and M&A
  • Project Finance and Tax Credit Transactions
  • Sustainability and Decarbonization
  • Transportation Electrification

  • U.S. Expansion Library and Resources

  • Post-Grant Review
  • Trademark and Advertising

  • Antitrust Litigation
  • Arbitration
  • Board and Internal Investigations
  • Class Action Litigation
  • Commercial Litigation
  • Consumer Litigation
  • Corporate Governance Litigation
  • Employment Litigation
  • Executive Branch Updates
  • Government Investigations
  • Internet Strategy and Litigation
  • Patent Litigation
  • Securities Litigation
  • State Attorneys General
  • Supreme Court and Appellate Practice
  • Trade Secret Litigation
  • Trademark and Copyright Litigation
  • Trial
  • White Collar Crime

  • Advertising, Promotions, and Marketing
  • Antitrust and Competition
  • Committee on Foreign Investment in the U.S. (CFIUS)
  • Communications
  • Data, Privacy, and Cybersecurity
  • Export Control and Sanctions
  • FCPA and Anti-Corruption
  • FDA Regulatory, Healthcare, and Consumer Products
  • Federal Trade Commission
  • Fintech and Financial Services
  • Government Contracts
  • National Security and Trade
  • Payments
  • State Attorneys General
  • Strategic Risk and Crisis Management
  • Tariffs, Customs, and Import Compliance

  • Antitrust and Intellectual Property
  • Antitrust Civil Enforcement
  • Antitrust Compliance and Business Strategy
  • Antitrust Criminal Enforcement
  • Antitrust Litigation
  • Antitrust Merger Clearance
  • European Competition Law
  • Third-Party Merger and Non-Merger Antitrust Representation

  • Anti-Money Laundering
  • Foreign Ownership, Control, or Influence (FOCI)
  • Team Telecom

  • AI in Healthcare
  • Animal Health
  • Artificial Intelligence and Machine Learning
  • Aviation
  • Biotech
  • Blockchain and Cryptocurrency
  • Clean Energy
  • Climate and Clean Technologies
  • Communications and Networking
  • Consumer Products and Services
  • Data Storage and Cloud
  • Defense Tech
  • Diagnostics, Life Science Tools, and Deep Tech
  • Digital Health
  • Digital Media and Entertainment
  • Electronic Gaming
  • Fintech and Financial Services
  • FoodTech and AgTech
  • Global Generics
  • Internet
  • Life Sciences
  • Medical Devices
  • Mobile Devices
  • Mobility
  • NewSpace
  • Quantum Computing
  • Semiconductors
  • Software

  • Offices
  • Country Desks
  • Events
  • Community
  • Our Diversity
  • Sustainability
  • Our Values
  • Board of Directors
  • Management Team

  • Austin
  • Boston
  • Boulder
  • Brussels
  • Century City
  • Hong Kong
  • London
  • Los Angeles
  • New York
  • Palo Alto
  • Salt Lake City
  • San Diego
  • San Francisco
  • Seattle
  • Shanghai
  • Washington, D.C.
  • Wilmington, DE

  • Law Students
  • Judicial Clerks
  • Experienced Attorneys
  • Patent Agents
  • Business Professionals
  • Alternative Legal Careers
  • Contact Recruiting
Christina L. Poulsen
Partner
Corporate
Palo Alto
cpoulsen@wsgr.com

D650-849-3245

Download vCard
LinkedIn
Open PDF
  • Extensive Corporate Law Experience

    Christina’s practice spans the full range of corporate transactions, including IPOs, follow-on and secondary offerings, venture-backed private financings, and M&A. She also regularly represents companies in general corporate and securities matters.

  • A Recognized Practitioner

    Christina was named to the 2018 and 2019 editions of the “Rising Stars” list published by Northern California Super Lawyers.

Christina L. Poulsen is a partner in the Palo Alto office of Wilson Sonsini Goodrich & Rosati, where she practices corporate and securities law.

Christina represents public and private technology and life sciences companies, as well as financial institutions. Christina's practice spans the full range of corporate transactions, including initial public offerings, follow-on and secondary offerings, venture-backed private financings, and mergers and acquisitions. She also regularly represents companies in general corporate and securities matters, including corporate formation and structuring, corporate governance, and SEC reporting obligations.

 

Experience

Christina L. Poulsen is a partner in the Palo Alto office of Wilson Sonsini Goodrich & Rosati, where she practices corporate and securities law.

Christina represents public and private technology and life sciences companies, as well as financial institutions. Christina's practice spans the full range of corporate transactions, including initial public offerings, follow-on and secondary offerings, venture-backed private financings, and mergers and acquisitions. She also regularly represents companies in general corporate and securities matters, including corporate formation and structuring, corporate governance, and SEC reporting obligations.

 

Education
  • J.D., UC Davis School of Law
  • B.A., Philosophy and Government, Dartmouth College
Honors
  • Named to the 2018 and 2019 editions of the "Rising Stars" list published by Northern California Super Lawyers
Admissions
  • State Bar of California
Credentials
Education
  • J.D., UC Davis School of Law
  • B.A., Philosophy and Government, Dartmouth College
Honors
  • Named to the 2018 and 2019 editions of the "Rising Stars" list published by Northern California Super Lawyers
Admissions
  • State Bar of California

Select Speaking Engagements

  • Roundtable Co-lead, “IPO Readiness: Quiet Periods, Disclosures, and Comms,” The L Suite Senior VCGC Spring Forum, March 18-20, 2026
Insights

Select Speaking Engagements

  • Roundtable Co-lead, “IPO Readiness: Quiet Periods, Disclosures, and Comms,” The L Suite Senior VCGC Spring Forum, March 18-20, 2026
Focus Areas
  • Biotech
  • Capital Markets
  • Clean Energy
  • Communications and Networking
  • Corporate
  • Corporate Governance
  • Corporate Life Sciences
  • Emerging Companies and Venture Capital
  • Life Sciences
  • Medical Devices
  • Mergers & Acquisitions
  • Software
Recent Insights
Client Highlights
Firm Advises 137 Ventures and BANNER VC on Impulse Space’s $500 Million Series D Financing
On June 2, 2026, Impulse Space, an in-space mobility leader, announced it has raised $500 million in Series D funding, bringing the company’s total capital raised to over $1 billion. The funding will support the company’s hiring and manufacturing growth plans in its efforts to build in-space mobility infrastructure. The funding round was co-led by 137 Ventures and BANNER VC with participation from Founder’s Fund, Lux Capital, and Linse Capital. Wilson Sonsini Goodrich & Rosati advised 137 Ventures and BANNER VC on the transaction.
Learn More
Client Highlights
Wilson Sonsini Advises ALX Oncology on Public Offering
On January 30, 2026, ALX Oncology Holdings Inc., a clinical-stage biotechnology company focusing on novel therapies designed to treat cancer and extend patients’ lives, announced the pricing of an underwritten offering of 76,979,112 shares of common stock and, in lieu of common stock to certain investors, pre-funded warrants to purchase 18,574,120 shares of common stock in the offering. The gross proceeds of the offering are expected to be approximately $150 million before deducting the underwriting discounts and commissions and other estimated offering expenses, and excluding the exercise of any pre-funded warrants. Wilson Sonsini Goodrich & Rosati advised ALX Oncology on the transaction.
Learn More
View All
Recent Events
Affiliated Programs
Biotech CEO Summit 2025
Wilson Sonsini is proud to sponsor the Biotech CEO Summit in Napa, the premier conference designed exclusively for CEOs in the life science industry. The Summits focus on the participating CEOs discussing issues of importance to them as leaders of companies they want to position for growth and success. The Summits are discussion based meetings led by subject matter experts. All participants are invited to, and indeed encouraged to join the discussions by asking questions and sharing their personal insights. The Summits are run under Chatham House Rules to encourage open and frank conversation. 
Learn More
Affiliated Programs
NextGen VC Forum: Expanding Skills and Expertise Co-hosted with LaunchBio
Curated by Wilson Sonsini's Michael Hostetler and Dan Koeppen, LaunchBio’s NextGen VC Forum is the premiere event for venture capital associates to expand their skills and expertise while growing their network. The half-day forum includes a networking breakfast, three one-hour sessions and lunch. Attendance at NextGen VC Forum is by invitation only; if interested, please contact your firm’s senior partners.
Learn More
  • people
  • insights
  • about us
  • careers
  • Binder
  • Alumni
  • Mailing List Signup
  • Client FTP Portal
  • Privacy Policy
  • Terms of Use
  • Accessibility
WSGR logo
Twitter
LinkedIn
Facebook
Instagram
Youtube
Copyright © 2026 Wilson Sonsini Goodrich & Rosati. All Rights Reserved.